Clinical Trial Update: Bradykinin Receptor Blocker in ACE Inhibitor-associated Angioedema [Phase 1]

View source ↗

Summary

Phase 1 trial of a Bradykinin receptor blocker for ACE inhibitor-associated angioedema was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angioedema

Drugs mentioned

• Bradykinin Receptor Blocker

Snippet

Sponsor: Vanderbilt University | Conditions: Angioneurotic Edema | Phase 1 | Status: TERMINATED